MiR-485-3p and mir-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression

Cell Death and Disease

Volumn 7, Issue 3, 2016, Pages

  Lou, C ^a   Xiao, M ^a   Cheng, S ^a   Lu, X ^a   Jia, S ^a   Ren, Y ^a   Li, Z ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 485; MICRORNA 485 3P; MICRORNA 485 5P; MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCLASSIFIED DRUG; ATP5B PROTEIN, HUMAN; PPARGC1A PROTEIN, HUMAN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ADULT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTATIC BREAST CANCER; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MCF-7 CELL LINE; METABOLISM; MITOCHONDRION; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; SECONDARY; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA, MITOCHONDRIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; SEQUENCE ALIGNMENT;

EID: 85016276298     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.27     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
2. Scully OJ, Bay BH, Yip G, Yu Y. Breast cancer metastasis. Cancer Genomics Proteomics 2012; 9: 311–320.
3. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029–1033.
4. Warburg O. On the origin of cancer cells. Science 1956; 123: 309–314.
5. Locasale JW, Cantley LC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab 2011; 14: 443–451.
6. LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 2014; 16: 1001–1015.
7. Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics 2015; 5: 1122–1143.
8. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11: 228–234.
9. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857–866.
10. Liu YN, Yin J, Barrett B, Sheppard-Tillman H, Li D, Casey OM et al. Loss of androgen-regulated microRNA 1 activates SRC and promotes prostate cancer bone metastasis. Mol Cell Biol 2015; 35: 1940–1951.
11. Zhang Q, Tang Q, Qin D, Yu L, Huang R, Lv G et al. Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis. Mol Cell Biol 2015; 35: 988–1000.
12. Li X, Gong X, Chen J, Zhang J, Sun J, Guo M. miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2. Biochem Biophys Res Commun 2015; 460: 670–677.
13. Labbaye C, Testa U. The emerging role of MIR-146 A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol 2012; 5: 13.
14. Anaya-Ruiz M, Bandala C, Perez-Santos JL. miR-485 acts as a tumor suppressor by inhibiting cell growth and migration in breast carcinoma T47D cells. Asian Pac J Cancer Prev 2013; 14: 3757–3760.
15. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001; 107: 823–826.
16. Shao D, Liu Y, Liu X, Zhu L, Cui Y, Cui A et al. PGC-1 beta-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERR alpha. Mitochondrion 2010; 10: 516–527.
17. Zhou J, Tian Y, Li J, Lu B, Sun M, Zou Y et al. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. Biochem Biophys Res Commun 2013; 433: 207–212.
18. Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou X et al. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. Carcinogenesis 2014; 35: 469–478.
19. Costa FF, Bischof JM, Vanin EF, Lulla RR, Wang M, Sredni ST et al. Identification of microRNAs as potential prognostic markers in ependymoma. PloS One 2011; 6: e25114.
20. Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, Kim G et al. Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology 2010; 57: 734–743.
21. Chen CF, He X, Arslan AD, Mo YY, Reinhold WC, Pommier Y et al. Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIalpha and drug responsiveness. Mol Pharmacol 2011; 79: 735–741.
22. He N, Zheng H, Li P, Zhao Y, Zhang W, Song F et al. miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk. PloS One 2014; 9: e102093.
23. Lieber D. Generation of a stable cell line for constitutive miRNA expression. Methods Mol Biol 2013; 1064: 183–200.